​

Tevogen Bio Ownership | Who Owns Tevogen Bio?

OverviewFinancialsChart

Tevogen Bio Ownership Summary

Tevogen Bio is owned by 1.42% institutional investors, 91.61% insiders, and 6.98% retail investors.

TVGN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTevogen Bio1.42%91.61%6.98%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20244227.27%2,408,376-57.37%112.84%3233.33%6-
Sep 30, 20243322.22%5,649,636-0.60%324.43%24-4.00%6500.00%
Jun 30, 202427440.00%5,683,714-16.16%315.13%25400.00%1-
Mar 31, 20245-6,779,132-4-5---

Recent Insider Transactions

DateNameRoleActivityValue
Mar 12, 2025Flomenberg Neal See RemarksSell$253.94K
Mar 11, 2025Flomenberg Neal See RemarksSell$73.76K
Mar 10, 2025Flomenberg Neal See RemarksSell$76.72K
Mar 07, 2025Flomenberg Neal See RemarksSell$81.25K
Mar 06, 2025Flomenberg Neal See RemarksSell$97.37K

Insider Transactions Trends

DateBuySell
2025 Q1-7
2024 Q4-1
2024 Q22-
2024 Q1--

TVGN Ownership FAQ

Who Owns Tevogen Bio?

Tevogen Bio shareholders are primarily institutional investors at 1.42%, followed by 91.61% insiders and 6.97% retail investors. The average institutional ownership in Tevogen Bio's industry, Biotech Stocks , is 68.48%, which Tevogen Bio falls below.

Does Blackrock own Tevogen Bio?

BlackRock is not among the top 10 institutional shareholders of Tevogen Bio.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools